Scientific Publications

20Mar, 2015

Analyses of tramiprosate Phase 3 trials show improvement in cognition and function in APOE4 positive alzheimer’s disease subjects reaching 4 point improvement from placebo on ADAS-cog in homozygous APOE4 subjects, and support development of ALZ-801, a novel prodrug of tramiprosate with optimized drug properties

March 20th, 2015|Categories: Publications|

Presented at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases in Nice, France. [...]

Load More